Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Genetic Technologies Ltd

GeneType featured on U.S. National TV to raise Breast Cancer Awareness
From Genetic Technologies Ltd
Via GlobeNewswire
Tickers ASX:GTG GENE
New Publication Validates geneType for Melanoma Risk Assessment
From Genetic Technologies Ltd
Via GlobeNewswire
Tickers ASX:GTG GENE
Quarterly Business Update – March 2023
From Genetic Technologies Ltd
Via GlobeNewswire
Tickers ASX:GTG GENE
Publication Validates geneType Prostate Cancer Risk Test
From Genetic Technologies Ltd
Via GlobeNewswire
Tickers ASX:GTG GENE
GeneType Multi-Risk Test now includes Melanoma, Pancreatic Cancer & Atrial Fibrillation
From Genetic Technologies Ltd
Via GlobeNewswire
Tickers ASX:GTG GENE
Back-to-back Studies Validate geneType Breast Cancer Risk Test
From Genetic Technologies Ltd
Via GlobeNewswire
Tickers ASX:GTG GENE
New Publication Highlights geneType’s Ability to Detect Breast Cancer Earlier and Provide Data for Risk Stratification
From Genetic Technologies Ltd
Via GlobeNewswire
Tickers ASX:GTG GENE
Genetic Technologies Announces $5 Million Registered Direct Offering
From Genetic Technologies Ltd
Via GlobeNewswire
Tickers ASX:GTG GENE
GENE to Launch World’s First Comprehensive Risk Test for Breast & Ovarian Cancer
From Genetic Technologies Ltd
Via GlobeNewswire
Tickers ASX:GTG GENE
GTG to form Strategic Alliance with global testing leader QIAGEN
From Genetic Technologies Ltd
Via GlobeNewswire
Tickers ASX:GTG GENE
Quarterly Business Update – December 2022; Sixth Consecutive Quarter of Growth
From Genetic Technologies Ltd
Via GlobeNewswire
Tickers ASX:GTG GENE
Genetic Technologies Presented Improved Clinical Colorectal Cancer Risk Prediction Model Integrating Polygenic Risk at ASCOGI Cancer Symposium
From Genetic Technologies Ltd
Via GlobeNewswire
Tickers ASX:GTG GENE
Genetic Technologies Provides Business Update
From Genetic Technologies Ltd
Via GlobeNewswire
Tickers ASX:GTG GENE
GeneType published in PLOS ONE – development of polygenic risk scores for cardiovascular diseases and type 2 diabetes
From Genetic Technologies Ltd
Via GlobeNewswire
Tickers ASX:GTG GENE
Webinar - Dr Erika Spaeth to interview A/Prof Charles Siles on risk assessment tests for serious disease
From Genetic Technologies Ltd
Via GlobeNewswire
Tickers ASX:GTG GENE
Genetype for Ovarian Cancer Published in Prestigious European Journal of Cancer Prevention
From Genetic Technologies Ltd
Via GlobeNewswire
Tickers ASX:GTG GENE
Journal of Precision Medicine publication confirms GeneType Risk Test outperforms traditional risk assessments for breast cancer
From Genetic Technologies Ltd
Via GlobeNewswire
Tickers ASX:GTG GENE
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.